Search research articles
Contact Us
Filters
Showing results (11-20 of 185) with videos related to
Page
of 19
Sort By:
Cancer Biotherapy & Radiopharmaceuticals
|
March 21, 2020
Comparative <i>In Vitro</i> Cytotoxicity Studies of <sup>177</sup>Lu-CHX-A″-DTPA-Trastuzumab and <sup>177</sup>Lu-CHX-A″-DTPA-F(ab')<sub>2</sub>-Trastuzumab in HER2-Positive Cancer Cell Lines
Rohit Sharma, Mythili Kameswaran, Ashutosh Dash
Cancer Biotherapy & Radiopharmaceuticals
|
May 19, 2012
Nafion-zirconium phosphate composite membrane: a new approach to prepare (32)P patches for superficial brachytherapy applications
Sanjay Kumar Saxena, Yogendra Kumar, Ashutosh Dash
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine
|
April 7, 2018
Improved freeze-dried kit for the preparation of <sup>188</sup>ReN-DEDC/lipiodol for the therapy of unresectable hepatocellular carcinoma
Madhava B Mallia, Viju Chirayil, Ashutosh Dash
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine
|
March 7, 2017
Preclinical evaluation of <sup>131</sup>I-Bevacizumab - A prospective agent for radioimmunotherapy in VEGF expressing cancers
Mythili Kameswaran, Haladhar Dev Sarma, Ashutosh Dash
Evaluation Review
|
July 25, 2024
Funding Innovation and Risk: A Grey-Based Startup Investment Decision
Manoj Kumar Srivastava, Ashutosh Dash, Imlak Shaikh
Journal of Labelled Compounds & Radiopharmaceuticals
|
February 21, 2018
Preparation and preliminary in vivo evaluation of <sup>166</sup> Ho-labeled microspheres for possible use in radioembolic therapy of liver cancer
Suresh Subramanian, K V Vimalnath, Ashutosh Dash
Journal of Labelled Compounds & Radiopharmaceuticals
|
January 22, 2019
Preparation of <sup>177</sup> Lu-labeled Nimotuzumab for radioimmunotherapy of EGFR-positive cancers: Comparison of DOTA and CHX-A″-DTPA as bifunctional chelators
Usha Pandey, Mythili Kameswaran, Naresh Gamre, et al.
Current Radiopharmaceuticals
|
May 31, 2012
Electrochemical separation is an attractive strategy for development of radionuclide generators for medical applications
Rubel Chakravarty, Ashutosh Dash, M R A Pillai
Nuclear Medicine and Biology
|
February 1, 2014
Reactor production and electrochemical purification of (169)Er: a potential step forward for its utilization in in vivo therapeutic applications
Rubel Chakravarty, Sudipta Chakraborty, Viju Chirayil, et al.
Current Medicinal Chemistry
|
February 5, 2019
Targeted Radionuclide Therapy of Painful Bone Metastases: Past Developments, Current Status, Recent Advances and Future Directions
Ashutosh Dash, Tapas Das, Furn F Russ Knapp
Page
of 19
Search research articles
Search
Showing results (11-20 of 185) with videos related to
Sort By:
Page
of 19
Cancer Biotherapy & Radiopharmaceuticals
|
March 21, 2020
Comparative <i>In Vitro</i> Cytotoxicity Studies of <sup>177</sup>Lu-CHX-A″-DTPA-Trastuzumab and <sup>177</sup>Lu-CHX-A″-DTPA-F(ab')<sub>2</sub>-Trastuzumab in HER2-Positive Cancer Cell Lines
Rohit Sharma, Mythili Kameswaran, Ashutosh Dash
Cancer Biotherapy & Radiopharmaceuticals
|
May 19, 2012
Nafion-zirconium phosphate composite membrane: a new approach to prepare (32)P patches for superficial brachytherapy applications
Sanjay Kumar Saxena, Yogendra Kumar, Ashutosh Dash
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine
|
April 7, 2018
Improved freeze-dried kit for the preparation of <sup>188</sup>ReN-DEDC/lipiodol for the therapy of unresectable hepatocellular carcinoma
Madhava B Mallia, Viju Chirayil, Ashutosh Dash
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine
|
March 7, 2017
Preclinical evaluation of <sup>131</sup>I-Bevacizumab - A prospective agent for radioimmunotherapy in VEGF expressing cancers
Mythili Kameswaran, Haladhar Dev Sarma, Ashutosh Dash
Evaluation Review
|
July 25, 2024
Funding Innovation and Risk: A Grey-Based Startup Investment Decision
Manoj Kumar Srivastava, Ashutosh Dash, Imlak Shaikh
Journal of Labelled Compounds & Radiopharmaceuticals
|
February 21, 2018
Preparation and preliminary in vivo evaluation of <sup>166</sup> Ho-labeled microspheres for possible use in radioembolic therapy of liver cancer
Suresh Subramanian, K V Vimalnath, Ashutosh Dash
Journal of Labelled Compounds & Radiopharmaceuticals
|
January 22, 2019
Preparation of <sup>177</sup> Lu-labeled Nimotuzumab for radioimmunotherapy of EGFR-positive cancers: Comparison of DOTA and CHX-A″-DTPA as bifunctional chelators
Usha Pandey, Mythili Kameswaran, Naresh Gamre, et al.
Current Radiopharmaceuticals
|
May 31, 2012
Electrochemical separation is an attractive strategy for development of radionuclide generators for medical applications
Rubel Chakravarty, Ashutosh Dash, M R A Pillai
Nuclear Medicine and Biology
|
February 1, 2014
Reactor production and electrochemical purification of (169)Er: a potential step forward for its utilization in in vivo therapeutic applications
Rubel Chakravarty, Sudipta Chakraborty, Viju Chirayil, et al.
Current Medicinal Chemistry
|
February 5, 2019
Targeted Radionuclide Therapy of Painful Bone Metastases: Past Developments, Current Status, Recent Advances and Future Directions
Ashutosh Dash, Tapas Das, Furn F Russ Knapp
Page
of 19